ALLIANCEBERNSTEIN L.P. - PRELUDE THERAPEUTICS INC ownership

PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 52 filers reported holding PRELUDE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of PRELUDE THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$148,000
-49.3%
21,500
-8.4%
0.00%
Q4 2021$292,000
-31.8%
23,468
+71.3%
0.00%
Q3 2021$428,000
-16.4%
13,700
-23.5%
0.00%
Q2 2021$512,000
+13.5%
17,900
+72.1%
0.00%
Q1 2021$451,000
-26.7%
10,400
+20.9%
0.00%
Q4 2020$615,0008,6000.00%
Other shareholders
PRELUDE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Orbimed Advisors 10,039,691$69,274,0001.12%
Baker Brothers Advisors 10,123,824$69,854,0000.40%
HHLR ADVISORS, LTD. 583,333$4,025,0000.08%
Rock Springs Capital Management LP 368,959$2,546,0000.06%
PDT Partners, LLC 71,822$496,0000.04%
Virtus ETF Advisers LLC 13,048$90,0000.04%
Corton Capital Inc. 10,918$75,0000.03%
GSA CAPITAL PARTNERS LLP 23,201$160,0000.02%
OCCUDO QUANTITATIVE STRATEGIES LP 24,238$167,0000.01%
IndexIQ Advisors LLC 56,750$392,0000.01%
View complete list of PRELUDE THERAPEUTICS INC shareholders